Concord Drugs Fact Sheet, Concord Drugs Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Concord Drugs Fact Sheet    (CODL)


EV Stocks: Make a Fortune from Automobile Sector's Colossal Disruption


Here is the latest financial fact sheet of Concord Drugs. For more details, see the Concord Drugs quarterly results and Concord Drugs share price and chart. For a sector overview, read our pharmaceuticals sector report.

CONCORD DRUGS Price History

Price Rs 34.8
Mkt Cap Rs m 273
Vol '000 19.7
P/E X 7.2
P/CF X 15.2
EPS (TTM) Rs 4.8
% ch % 1.9
No. of shares m 7.86
% ch week % 6.9
% ch 1-mth % 33.7
% ch 12-mth % 11.2
52 week H/L Rs 45.0/20.8
(As on Oct 14, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

CONCORD DRUGS Financials

No. of Mths
Year Ending
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
5-Yr Chart
Click to enlarge
CONCORD DRUGS EQUITY SHARE DATA
High Rs9179643424 
Low Rs4246231512 
Sales per share (Unadj.) Rs70.079.465.961.258.7 
Earnings per share (Unadj.) Rs2.40.20.40.50.4 
Diluted earnings per shareRs2.20.20.40.50.4 
Cash flow per share (Unadj.) Rs6.43.83.52.72.1 
Dividends per share (Unadj.) Rs00000 
Adj. dividends per shareRs0.000.000.000.000.00 
Avg Dividend yield %00000 
Book value per share (Unadj.) Rs20.826.224.629.526.9 
Adj. book value per shareRs19.224.224.629.529.9 
Shares outstanding (eoy) m7.247.247.867.868.74 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x1.00.80.70.40.3 
Avg P/E ratio x27.7285.3104.947.046.9 
P/CF ratio (eoy) x10.416.612.59.08.6 
Price / Book Value ratio x3.22.41.80.80.7 
Dividend payout %00000 
Avg Mkt Cap Rs m484455340191154 
No. of employees `000NANANANANA 
Total wages/salary Rs m1626172333 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
CONCORD DRUGS INCOME DATA
Net Sales Rs m507575518481513 
Other income Rs m22411 
Total revenues Rs m509576522482515 
Gross profit Rs m8255463733 
Depreciation Rs m2926241715 
Interest Rs m2624191615 
Profit before tax Rs m306645 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m125301 
Profit after tax Rs m172343 
Gross profit margin %16.39.68.87.66.5 
Effective tax rate %41.075.449.27.528.1 
Net profit margin %3.40.30.60.80.6 
CONCORD DRUGS BALANCE SHEET DATA
Current assets Rs m365302920697456 
Current liabilities Rs m208293807561310 
Net working cap to sales %31.11.521.828.428.4 
Current ratio x1.81.01.11.21.5 
Inventory Days Days674677 
Debtors Days Days18399502368181 
Net fixed assets Rs m160254144130125 
Share capital Rs m7272797987 
"Free" reserves Rs m78117115153147 
Net worth Rs m151190193232235 
Long term debt Rs m122623479 
Total assets Rs m5255551,064828580 
Interest coverage x2.21.31.31.31.3 
Debt to equity ratio x0.80.30.200 
Sales to assets ratio x1.01.00.50.60.9 
Return on assets %8.24.72.12.43.2 
Return on equity %11.60.81.71.81.4 
Return on capital %20.312.211.18.58.2 
Exports to sales %00000 
Imports to sales %00000 
Exports (fob) Rs m00000 
Imports (cif) Rs m00000 
Fx inflow Rs m21000 
Fx outflow Rs m00000 
Net fx Rs m21000 
CONCORD DRUGS CASH FLOW
From Operations Rs m 36 17 69 12 22 
From Investments Rs m 2 -10 -22 -3 -8 
From Financial Activity Rs m -39 -39 -48 -7 -15 
Net Cashflow Rs m 0 -33 -1 1 -1 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 44.4%
Institution 0.0%
Non-Institution 55.6%
Total 100.0%
Free Float 55.6%
Pledged promoter holdings 0.0%
 

Company Information

REGD OFF Survey No.249 Brahmanapally Village, Hayatnagar Mandal, R R Dist, Hyderabad - 501511
E-MAIL concorddrugsltd@gmail.com WEB www.concorddrugs.in
TEL 91-040 24036379/24037763 FAX
SECTOR PHARMACEUTICALS GROUP Private sector
TR AGENT Aarthi Consultants Pvt Ltd, 1-2-285, Domalaguda
YEAR OF INC: 1995 BSE CODE: 538965 FV (Rs): 10 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   CHOKSI LAB.  BAL PHARMA  TTK HEALTHCARE  FERMENTA BIOTECH  BAFNA PHARMA  

Compare CONCORD DRUGS With:   CHOKSI LAB.  BAL PHARMA  TTK HEALTHCARE  FERMENTA BIOTECH  BAFNA PHARMA  




Today's Market

Sensex Ends Above 61,000-Mark, Nifty Tops 18,300; Adani Ports, Wipro & Grasim Rally 5%(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended on a strong note.

Views on news

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Apollo Hospitals' Shares Rally Over 5%, Hit Record-High on Strong Results (Views On News)

Aug 16, 2021

The company reported a 73% YoY increase in revenue driven by an uptick in the hospital and pharmacy business.

J B Chemicals & Pharma's Decent Performance Puts Stock in Focus (Views On News)

Aug 13, 2021

The company seeks to expand the market for prescription lozenges with new launches this year.

More Views on News

Most Popular

Is it Time to Switch from Tata Power to NTPC? (Profit Hunter)

Oct 11, 2021

Given the huge run up in Tata Power, does it make sense to switch to NTPC?

This Proxy EV Stock Just got a Power Crisis Boost (Profit Hunter)

Oct 8, 2021

After months of research, I've come across few stocks that excite me far more than the mainstream electric vehicle companies.

Rs 1 Lakh Invested in These Cryptos at the Start of 2021 Became Rs... (Views On News)

Oct 8, 2021

These cryptos would have multiplied investors' wealth by as much as 10,000% in just nine months.

Top 5 'Digital India' Stocks (Views On News)

Oct 6, 2021

These companies are leading the Government's US$1 tn 'Digital India' initiative.

5 Exciting 'Unlisted' Companies and How to Play Them (Views On News)

Oct 7, 2021

Here's how you can invest in some of the most exciting start-ups of the decade.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK CONCORD DRUGS

  • Track your investment in CONCORD DRUGS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CONCORD DRUGS

CONCORD DRUGS 8-QTR ANALYSIS

COMPARE CONCORD DRUGS WITH

MARKET STATS